Related Experiment Videos
Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling
P Hjelmström1, C DeWeese-Scott, J E Penzotti
1Department of Molecular Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.
Journal of Neuroimmunology
|June 17, 1998
Summary
Myasthenia gravis (MG) involves muscle weakness from autoimmunity against the nicotinic acetylcholine receptor (nAChR). Structural differences in HLA-DQ molecules, particularly at peptide-anchor pockets, may influence binding of disease-related nAChR peptides.
Area of Science:
- Immunogenetics
- Molecular modeling
- Autoimmune diseases
Background:
- Myasthenia gravis (MG) is an autoimmune disorder causing muscle weakness.
- Autoimmunity in MG targets the nicotinic acetylcholine receptor (nAChR).
- Genetic associations between MG and HLA-DQ gene polymorphisms are known.
Purpose of the Study:
- To characterize structural differences in HLA-DQ peptide-binding grooves.
- To compare HLA-DQ molecules associated with MG susceptibility and resistance.
- To investigate the role of these structural differences in nAChR peptide binding.
Main Methods:
- Construction of three-dimensional models of HLA-DQ molecules using homology modeling.
- Analysis of structural differences in the peptide-binding groove.
- Identification of key peptide-anchor pockets (P7 and P9).
Main Results:
- Structural differences were identified between positively associated DQ2 (DQB1*02) and negatively associated DQ6 (DQB1*0603) molecules.
- These differences were localized to peptide-anchor pockets P7 and P9.
- The identified pockets are crucial for peptide binding.
Conclusions:
- Structural variations in HLA-DQ molecules influence peptide binding.
- Differences in peptide-anchor pockets P7 and P9 may be critical for binding nAChR-derived peptides in MG.
- This finding provides insights into the immunogenetic basis of myasthenia gravis.